Introduction
The first attempts of intraocular tumor biopsies reach far back in ophthalmic surgical history being credited to Hirschberg in 1868 [1] . During the first half of the 20th century, when large-bore needles and trephines were still used to obtain tissue specimens, these procedures were rarely performed and carried a significant risk of extraocular tumor seeding [1] . It was with the advent of microinvasive vitreoretinal surgery that intraocular biopsies became a feasible and more widely used diagnostic tool. New insights into the prognostic value of cytogenetical testing in uveal melanoma (UM) patients have led to a significant increase in the number of biopsies during the last 20 years.
Whether they are performed as vitrectomies or transvitreal or transscleral fine needle aspiration biopsies, the current biopsy techniques are considered as markedly safe [2, 3] . However, until this day, iatrogenic tumor cell seeding might still represent the potentially severest of all imaginable complications. Therefore, we want to report an extremely rare case of suspected tumor cell seeding following a transretinal tumor biopsy.
Keywords
Uveal melanoma · Transretinal biopsy · Local recurrence · Tumor cell seeding · Histopathology Abstract Background/Aims: To report a case and the histopathology of uveal melanoma cell seeding following transretinal tumor biopsy for a suspected uveal lesion. Methods: Interventional case report. Results: A 66-year-old male presented with a pigmented perilimbal episcleral lesion overlying an intraocular mass at the pars plana, 3.5 years after transretinal biopsy and ruthenium plaque brachytherapy for a choroidal melanoma at the posterior pole. The patient underwent enucleation of the eye. Histopathology confirmed a recurrence of uveal melanoma with intra-and extrascleral tumor portions. Serial sections revealed the posterior border of this newfound pars plana melanoma separated from the radiation scar by a viable and tumor-free choroidal area, thus failing to establish a continuity between secondary and primary tumor. Conclusion: Transretinal tumor biopsy is of high diagnostic and prognostic value in the management of uveal lesions, but also bears the potential risk for tumor cell seeding.
A 66-year-old male presented with a slightly prominent choroidal mass in the right eye localized in the inferotemporal quadrant posterior to the equator ( Fig. 1 a, b) . Although suspicious for UM, the atypical clinical appearance made it impossible to rule out differential diagnoses such as metastasis or lymphoma. Therefore, the patient underwent a 25-gauge 3-port pars plana vitrectomy (sclerotomies in the inferotemporal, superotemporal, and superonasal quadrants) and transretinal tumor biopsy. Histopathological evaluation confirmed UM. At the patient's request, cytogenetic analyses were performed revealing a prognostically unfavorable monosomy 3. The patient underwent ruthenium-106 plaque brachytherapy. During the following year, the tumor height decreased resulting in an atrophic scar.
After being lost to follow-ups for 1 year, he returned with a pigmented perilimbal episcleral lesion in the 10 o'clock position of the right eye ( Fig. 2 a) . Ultrasound biomicroscopy revealed a solid intraocular mass at the pars plana, underlying the visible extraocular portion ( Fig. 2 b) . Based on clinical and echographic findings, this newfound intraocular tumor did not seem to be connected to the original inferotemporal UM location. At the latter, no remaining tumor was detectable. After enucleation, histopathological evaluation confirmed the suspected intra-and extrascleral UM recurrence ( Fig. 2 c) , with Melan-A, HMB-45, and Ki-67 immunopositivity. Serial sections showed the posterior border of this newfound anterior tumor separated from the inferotemporal radiation scar by a viable and tumor-free choroidal area with some fibrotic alteration ( Fig. 2 d) . A continuity between the secondary and the primary tumor could thus not be established.
Discussion
With the intra-and extrascleral portions of the recurrence positioned adjacent to the superotemporal pars plana vitrectomy sclerotomy, it appears likely to us that the present case represents an example of biopsy-related tumor cell seeding. Alternatively, a continuous growth evolving from the margins of the original tumor -which might not have been sufficiently irradiated -could have arisen. However, histopathological serial sections failed to establish such continuity, making a recurrence "per continuitatem" unlikely. No active UM remnants were detectable throughout the radiation scar. Theoretically, in place of a recurrence, the anterior tumor could also represent a separate ciliary body UM with extrascleral extension. Indeed, this would be highly improbable, since the frequency of such unilateral so-called multiple UMs has been estimated at <1: 50,000,000 based on the minimal number of published cases [4] .
The authors have explicitly no intention to question the value of transretinal tumor biopsies. On the contrary, the latter is, without a doubt, a well-established tool. It is at the same time safe and eye globe conserving [5] . It allows establishing or confirming a diagnosis in clinically inconclusive cases and provides important prognostic information [6] . In the future, with the advent of targeted or personalized cancer therapies, it might also give essential information in order to adapt the treatment to the individual tumor's genetic background [7, 8] . The present case illustrates simultaneously the diagnostic and prognostic values of transretinal tumor biopsies as well as the potential risk for tumor cell seeding, even if this is extremely rare. In a detailed literature search, we were able to identify a total of only 6 cases of extraocular UM extension following different bioptic techniques including fine needle aspiration biopsies [9] [10] [11] ( Table 1 ). The risk for tumor cell seeding, however, cannot be fully excluded and should therefore be considered when opting for biopsy and while performing surgery. Additionally, it should be mentioned when obtaining informed consent from patients. That is because both local recurrence and extraocular extension, which may result from iatrogenic tumor cell seeding, decrease the patients' chance of a tumor-free survival [12, 13] . Fortunately in our case, and despite recurrence and monosomy 3, neither hepatic nor other distant metastases have been detected during the 5-year follow-up period since the initial diagnosis. 
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